Georgia Prevention Institute
Augusta, Georgia, 30912, United States
Location status: Recruiting
NCT Number: NCT06236581
The purpose of this study is to see if the GEM intervention is acceptable and helpful to Black adults with type 2 diabetes. The GEM intervention (coaching to reduce carbohydrate intake and increase physical activity after meals, with feedback from a continuous glucose monitor, CGM) might improve blood glucose levels, reduce diabetes distress, and increase empowerment and confidence in managing diabetes.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Augusta, Georgia, 30912, United States
Location status: Recruiting
The purpose of the study is to test the feasibility, acceptability, and initial efficacy of the tailored GEM intervention among adult Black patients with type 2 diabetes, who are not on insulin or secretagogues.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lifestyle coaching
Time frame: Baseline week and post-intervention week. From baseline week to the week after end of intervention or waitlist period, up to 6 weeks
Difference in percent of time in range (70-180 mg/dL) from continuous glucose monitor data. Change = post intervention week minus baseline week.
Contact information is provided by the study sponsor or research team.
Catherine Davis
Other
Glycemic Excursion Minimization (GEM) to Outshine Health Disparities: RCT
Acronym: GEM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07441655
Behavior, Chronic Disease
Albany, Georgia, United States
View Trial DetailsNCT07005362
Artificial Intelegence, Behavior
Aurora, Colorado, United States
View Trial DetailsNCT07583355
Behavior, Diabetes Mellitus
Perugia, PG, Italy
View Trial DetailsNCT07262788
Behavior, Body Weight
Herlev, Denmark
View Trial Details